Market Place
Sourcing Support
Martin Meeson appointed as CEO of Axplora
10 Apr 2024 //
PRESS RELEASE
Axplora plans €8m investment at French facility
30 Jan 2024 //
PRESS RELEASE
Axplora announces the appointment of its Scientific Advisory Board
13 Nov 2023 //
PRESS RELEASE
Axplora announces the appointment of its Scientific Advisory Board
13 Nov 2023 //
PRESS RELEASE
Axplora`s Ursodeoxycholic Receives 5-Year Renewed Registration
07 Nov 2023 //
PRESS RELEASE
Axplora appoints Dr. Stephan Haitz as President of its Novasep CDMO Business Unit
18 Oct 2023 //
PRESS RELEASE
Code of Business Conduct: a key milestone for Axplora’s compliance program
04 Oct 2023 //
PRESS RELEASE
A leading manufacturer of active, life-saving pharmaceutical ingredients: Axplora
02 Oct 2023 //
PRESS RELEASE
Axplora Unveils New cGMP Pilot Facility for Flow Chemistry
25 Jul 2023 //
PRESS RELEASE
A new cGMP pilot facility for flow chemistry
25 Jul 2023 //
PRESS RELEASE
Axplora Aims to Make Pharmaceutical Supply Chains More Stable
22 Mar 2023 //
CHEMANAGER
Exclusive negotiations with InnovaFonds on the acquisition of Novasep Process Solutions
02 Feb 2023 //
PRESS RELEASE
Axplora Receives Pharmaceutical Establishment License for Le Mans Site
15 Dec 2022 //
CONTRACTPHARMA
Axplora, the partner of choice for complex APIs
27 Oct 2022 //
CPHI-ONLINE
Farmabios, Novasep and PharmaZell are now Axplora
20 Oct 2022 //
PRESS RELEASE
Farmabios, Novasep & PharmaZell are now one Group: Axplora
30 Sep 2022 //
CPHI ONLINE
Novasep-PharmaZell invests €7.3M to increase API production capacity at Mourenx site
21 Jul 2022 //
PRESS RELEASE
Safe HPAPI manufacturing: Thinking outside the glovebox!
20 Jul 2022 //
PRESS RELEASE
The French bioproduction sector announces the launch of a platform
07 Apr 2022 //
PRESS RELEASE
PharmaZell and Novasep announce the creation of a leading CDMO and API manufacturer
07 Apr 2022 //
PRESS RELEASE
Novasep enters the Jungle
01 Apr 2022 //
PRESS RELEASE
Novasep invests €5.1 million in Le Mans to further expand its production HPAPIs
15 Mar 2022 //
PRESS RELEASE
Novasep & Paratek enhance collaboration to manufacture omadacycline (NUZYRA®)
15 Feb 2022 //
PRESS RELEASE
Sartorius completes acquisition of Novasep’s chromatography equipment division
02 Feb 2022 //
PRESS RELEASE
Novasep signs a letter of intent Pfizer to bepart of the global supply PAXLOVID
17 Jan 2022 //
PRESS RELEASE
Novasep Invests €6M to Expand API Capacity at Chasse-sur-Rhône
09 Dec 2021 //
CONTRACTPHARMA
Fitch Affirms European Medco Development 3 S.a.r.l.`s IDR at `B` on Novasep Acquisition
25 Oct 2021 //
FITCHRATINGS
Teriflunomide – API and Licensing Agreements for Tablets available
06 Oct 2021 //
PRESS RELEASE
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
PharmaZell and Novasep discuss merger to create leader in small molecules
17 Sep 2021 //
PRESS RELEASE
PharmaZell Group will be attending CPHI 2021 – make appointments to visit us in Milano at booth 18J10
27 Aug 2021 //
PRESS RELEASE
Update on 5-ASA New Project in Vizag (India)
08 Jul 2021 //
PRESS RELEASE
Novasep secures manufacturing deal with US biotech for ADC drug candidate
06 Jul 2021 //
BIOPHARMA REPORTER
Novasep Upgrades API Manufacturing Facility
25 Jun 2021 //
CONTRACTPHARMA
Novasep invests $7.3M in API manufacturing facility in France
24 Jun 2021 //
BIOSPECTRUMASIA
Novasep Expands HPAPI Manufacturing Capacity
13 May 2021 //
CONTRACTPHARMA
Novasep upgrades plant capacity for next-gen cancer meds
11 May 2021 //
FIERCEPHARMA
EU validates Farmabios Cannabidiol (CBD) Ingredient for Novel Food
20 Apr 2021 //
PRESS RELEASE
CEO speaks at 25th Anniversary of PharmaZell plant in Chennai
23 Feb 2021 //
PRESS RELEASE
CEO Appreciating COVID Warriors
23 Feb 2021 //
PRESS RELEASE
JPM: Thermo Fisher picks up Novasep’s viral vector arm for $878M
15 Jan 2021 //
FIERCE BIOTECH
PharmaZell – Update on new Mesalazine production building in Vizag (India)
12 Jan 2021 //
PRESS RELEASE
Sartorius Stedim Biotech to acquire Novasep`s chromatography process division
06 Jan 2021 //
BIOSPACE
Novel Food Ingredient registration – synthetic CBD
04 Dec 2020 //
PRESS RELEASE
Novasep to Invest $7.6 million to Expand API Manufacturing Workshop Capacity
11 Nov 2020 //
PHARMTECH
Novasep invests €6.5 million in accelerating API manufacturing in France
10 Nov 2020 //
BIOSPECTRUMASIA
Sensorion and Novasep Announce Signature of a Gene Therapy
27 Oct 2020 //
BUSINESSWIRE
Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios
14 Oct 2020 //
PRESS RELEASE
New ISO Certificates for FarmaBios (Gropello Cairoli, Italy)
23 Sep 2020 //
PRESS RELEASE
FarmaBios – Update on new warehouse in Gropello Cairoli (Italy)
16 Sep 2020 //
PRESS RELEASE
PharmaZell (India) Private Limited. – Vizag
02 Sep 2020 //
PRESS RELEASE
PharmaZell announces that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility
16 Jul 2020 //
PRESS RELEASE
Frontier Biotech chooses Novasep HPLC columns skids for peptide purification
08 Jul 2020 //
PRESS RELEASE
Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)
07 Jul 2020 //
PRESS RELEASE
Coronavirus:NOVASEP partners with ASTRAZENECA to produce Covid-19 Oxford vaccine
15 Jun 2020 //
PRESS RELEASE
Fitch Assigns European Medco Development 3 S.a.r.l. First-Time `B(EXP)` IDR
09 Jun 2020 //
PRESS RELEASE
